InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Sullivan Lara, 董事长兼首席执行官. Officer active across 1 company, notably Pyxis Oncology, Inc.. Cumulatively, 7 disclosures have been logged. Split: 0 buy · 2 sells. Total volume traded: €42k. History available since 31 March 2022. The latest transaction was filed on 14 September 2023 (Cession). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Sullivan Lara is Président-Directeur Général and is linked to Pyxis Oncology, Inc. (XNAS), where the listed role is President and CEO. The record shows 7 filings in total, and across the 7 sampled filings from 2022-04-04 to 2023-09-18, the transactions include EUR 42456 of sales and EUR 0 of purchases, with Attribution as the dominant transaction nature.